ArticleDrug design, development and therapy2016

Efficacy and safety of iron-chelation therapy with deferoxamine, deferiprone, and deferasirox for the treatment of iron-loaded patients with nontransfusion-dependent thalassemia syndromes.

Ali T Taher et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.